PubMed

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.

Götte M, Kersting C, Radke I, Kiesel L, Wülfing P.

Breast Cancer Res. 2007;9(1):R8.PMID: 17244359 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.

Wülfing P, Kersting C, Buerger H, Mattsson B, Mesters R, Gustmann C, Hinrichs B, Tio J, Böcker W, Kiesel L.

Br J Cancer. 2005 May 9;92(9):1720-8.PMID: 15841074 [PubMed - indexed for MEDLINE]Related articlesFree article

Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.

Kim CH, Kim J, Kahng H, Choi EC.

Ann Surg Oncol. 2007 May;14(5):1565-74. Epub 2007 Feb 10.PMID: 17294073 [PubMed - indexed for MEDLINE]Related articles

Expression of scatter factor and c-met receptor in benign and malignant breast tissue.

Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM.

Cancer. 1997 Feb 15;79(4):749-60.PMID: 9024713 [PubMed - indexed for MEDLINE]Related articlesFree article

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.

Nakopoulou L, Gakiopoulou H, Keramopoulos A, Giannopoulou I, Athanassiadou P, Mavrommatis J, Davaris PS.

Histopathology. 2000 Apr;36(4):313-25.PMID: 10759945 [PubMed - indexed for MEDLINE]Related articles

Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.

Lindemann K, Resau J, Nährig J, Kort E, Leeser B, Annecke K, Welk A, Schäfer J, Vande Woude GF, Lengyel E, Harbeck N.

Histopathology. 2007 Jul;51(1):54-62.PMID: 17593080 [PubMed - indexed for MEDLINE]Related articles

Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ.

Yu M, Tang Z, Alousi S, Berk RS, Miller F, Kosir MA.

Am J Surg. 2007 Nov;194(5):594-9.PMID: 17936419 [PubMed - indexed for MEDLINE]Related articles

Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.

Miyata Y, Sagara Y, Kanda S, Hayashi T, Kanetake H.

Hum Pathol. 2009 Apr;40(4):496-504. Epub 2009 Jan 3.PMID: 19121849 [PubMed - indexed for MEDLINE]Related articles

Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.

Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2005 May-Jun;25(3A):1615-22.PMID: 16033070 [PubMed - indexed for MEDLINE]Related articles

Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.

Vogl G, Dietze O, Hauser-Kronberger C.

Histopathology. 2005 Dec;47(6):617-24.PMID: 16324200 [PubMed - indexed for MEDLINE]Related articles

An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1.

Pap Z, Pávai Z, Dénes L, Kovalszky I, Jung J.

Pathol Oncol Res. 2009 Dec;15(4):579-87. Epub 2009 Mar 1.PMID: 19253033 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.

Vestey SB, Perks CM, Sen C, Calder CJ, Holly JM, Winters ZE.

Breast Cancer Res. 2005;7(1):R119-29. Epub 2004 Nov 23.PMID: 15642160 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.PMID: 17649807 [PubMed - indexed for MEDLINE]Related articles

Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Rice AJ, Steward MA, Quinn CM.

J Clin Pathol. 2002 Dec;55(12):921-5.PMID: 12461058 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2004 Dec 1;10(23):7965-71.PMID: 15585631 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.

Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, Mesbah A.

Cancer Biomark. 2009;5(1):1-8.PMID: 19242056 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical categorisation of ductal carcinoma in situ of the breast.

Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ.

Br J Cancer. 2008 Jan 15;98(1):137-42. Epub 2007 Nov 27.PMID: 18043578 [PubMed - indexed for MEDLINE]Related articlesFree article

Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.

Safwat MD, Habib F, Elayat A, Oweiss N, Reffat S, Algaidi S.

Folia Morphol (Warsz). 2009 Aug;68(3):144-55.PMID: 19722158 [PubMed - indexed for MEDLINE]Related articles

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M.

Carcinogenesis. 2009 Mar;30(3):397-407. Epub 2009 Jan 6.PMID: 19126645 [PubMed - indexed for MEDLINE]Related articlesFree article

E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.

Mitselou A, Ioachim E, Peschos D, Charalabopoulos K, Michael M, Agnantis NJ, Vougiouklakis T.

Exp Oncol. 2007 Mar;29(1):54-60.PMID: 17431390 [PubMed - indexed for MEDLINE]Related articles